Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kozo Akasaka is active.

Publication


Featured researches published by Kozo Akasaka.


Xenobiotica | 1994

Application of pharmacokinetic studies to a novel antidepressant, E2011

T. Naitoh; Toru Horie; Satoshi Nagato; Takaki Kagaya; Atsuhiko Kubota; Kozo Akasaka

1. The original drug tested here, (5R)-3-[2-(3-cyanopropyl)benzothiazol-6-yl]-5-methoxymethyl-2-oxaz olidinone (ER-4539), exhibited strong MAO-A inhibitory activity in vitro, but its bioavailability in rat was very low. After ER-4539 was administered orally to dog, a metabolite was found in plasma. 2. The metabolite was isolated by hplc after incubation with dog liver microsomal preparations. Its structure, determined by ms and nmr analysis, was alpha-hydroxy-ER-4539. The configuration of the alpha-hydroxy metabolite was (S), determined in comparison with the authentic sample of (R) and (S) by hplc. The isolated metabolite had potent MAO-A inhibitory action in vitro, indicating that it would have antidepressant action. 3. (5R)-3-[2-((1S)-3-Cyano-1-hydroxypropyl)benzothiazol-6-yl]-5- methoxymethyl-2-oxazolidinone (E2011), the synthesized metabolite, has been improved in regard to biopharmaceutical characteristics in rat and dog.


Archive | 1988

Benzothiazole derivative, its use, and pharmaceutical compositions comprising it

Shinya Abe; Mitsuaki Miyamoto; Masayuki Tanaka; Kozo Akasaka; Kenji Hayashi; Tetsuya Kawahara; Toshi Katayama; Yoshinori Sakuma; Takeshi Suzuki; Isao Yamatsu


Archive | 1995

Biphenylderivatives, process for their preparation and their use as medicaments

Kozo Akasaka; Masahiro Yonaga; Akiharu Kajiwara; Kunizo Higurashi; Kohshi Ueno; Satoshi Nagato; Makoto Komatsu; Noritaka Kitazawa; Masataka Ueno; Yoshiharu Yamanishi; Yoshimasa Machida; Yuki Komatsu; Naoyuki Shimomura; Norio Minami; Toshikazu Shimizu; Atsushi Nagaoka


Archive | 1991

Benzene, pyridine and pyrimidine derivative

Teiji Kimura; Nobuhisa Watanabe; Yasutaka Takase; Kenji Hayashi; Makoto Matsui; Hironori Ikuta; Youji Yamagishi; Kozo Akasaka; Hiroshi Tanaka; Issei Ohtsuka; Takao Saeki; Motoji Kogushi; Tohru Fujimori; Isao Saito


Archive | 1989

Diphenylethylene derivatives, pharmaceutical compositions containing same and treatment methods

Youji Yamagishi; Kozo Akasaka; Takeshi Suzuki; Mitsuaki Miyamoto; Kouji Nakamoto; Kazuo Okano; Shinya Abe; Hironori Ikuta; Kenji Hayashi; Hiroyuki Yoshimura; Tohru Fujimori; Koukichi Harada; Isao Yamatsu


Archive | 1986

2-Pyrrolidone derivatives, process for preparing them, pharmaceutical composition and use

Hironori Ikuta; Youji Yamagishi; Kozo Akasaka; Isao Yamatsu; Seiichi Kobayashi; Hiroshi Shirota; Kouichi Katayama


Archive | 1982

A process for preparing an optically active d-alpha-tocopherol and compounds for its preparation

Kimiko Hamamura; Kozo Akasaka; Voji Yamagishi


Archive | 1992

Oxazolidone derivatives as monoamine oxidase inhibitors

Kozo Akasaka; Youichi Iimura; Takaki Kagaya; Akiharu Kajiwara; Mariko Komatsu; Atsuhiko Kubota; Masanori Mizuno; Satoshi Nagato; Atsushi Sasaki; Ichirou Yoshida


Chemical & Pharmaceutical Bulletin | 1999

Synthesis of a New Dual Metalloprotease Inhibitor. II. Stereoselective Synthesis of Peptidomimetic [5.7]-Bicyclic Compounds

Kozo Akasaka; Yuki Komatsu; Katsuya Tagami; Toshikazu Shimizu; Naoyuki Shimomura; Hiroshi Naka; Kenji Hayashi; Shigeto Negi


Archive | 1982

SYNTHESIS OF OPTICALLY ACTIVE D-.alpha. TOCOPHEROL

Youji Yamagishi; Kozo Akasaka; Kimio Hamamura

Collaboration


Dive into the Kozo Akasaka's collaboration.

Researchain Logo
Decentralizing Knowledge